ABOUT
Meet our team
A cross-functional team of scientists, clinicians and drug developers relentlessly pursuing treatments for inherited channelopathies, cardiometabolic diseases and cardiomyopathies.
Leadership
Paul F. Truex, MBA
Chairman of the Board & Chief Executive Officer
Debra Odink, PhD
President & Chief Development Officer
Read biography →
Amy Sehnert, MD, FACC
Chief Medical Officer
Read biography →
Matt Killeen, PhD
Chief Business Officer
Read biography →
Saumya Das, MD, PhD
Chief Scientific Advisor
Read biography →
Aidan McNeil, JD, BCL
Senior Vice President, Administration & Associate General Counsel
Read biography →
Team
Dinesh Srinivasan, PhD
Vice President, Strategic Portfolio Management
Read biography →
Alexandre Brkovic, PhD
Vice President, Clinical Research
Read biography →
Ashley Prasse Miller, MSc
Vice President, Clinical Operations
Read biography →
Marc Vidal, PhD
Vice President, Chemistry
Read biography →
Curtis McGrath, CPA
Vice President, Finance
Jennifer L. Strande, MD, PhD
Executive Director, Clinical Development
Read biography →
Justine Keller
Director, Finance
Read biography →
Delphine Labit, MSc
Director, Research
Read biography →
Alicia Schiavi, MSc
Associate Director, Clinical Operations
Read biography →
Maroua Khalifa, PhD
Associate Director, Pharmaceutical Development
Read biography →
Sabindra Pradhananga, PhD
Associate Director, Non-Clinical Development
Read biography →
Julie Vatté, PhD
Research Scientist
Read biography →
Kayluz Frias Boligan, PhD
Research Scientist
Read biography →
Brittany Hagen
Manager, Communications
Read biography →
Shannon Hewgill, MSc
Research Associate
Read biography →
Wenxia Luo, PhD
Postdoctoral Researcher, Dmpk
Read biography →
Philippe Beauclair, PhD
Postdoctoral Researcher, Chemistry
Read biography →
Cuihan Zhou, PhD
Postdoctoral Researcher, Chemistry
Read biography →